FDA Approves VALACYCLOVIR HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma Limited received FDA approval for the generic oral formulation of valacyclovir hydrochloride, allowing the company to enter a high-revenue market and compete with branded herpes antivirals. This approval is expected to drive significant volume growth for the API manufacturer by capitalizing on existing competition in the cardiovascular and antiviral segments.